Condition 1: Helicobacter pylori. Condition 2: Type 2 diabetes mellitus. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group: The intervention group will be treated with a four-drug anti-Helicobacter pylori regimen of bismuth + metronidazole + amoxicillin + omeprazole for 2 weeks. Diagnosi
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All asymptomatic diabetic patients whose Helicobacter pylori test is positive Informed consent of the patient regarding participation in the study
Exclusion criteria
Exclusion criteria: People with kidney failure, anemia and hemoglobinopathy History of antibiotic use in the last one month and proton pump inhibitor in the last two weeks Patients who had a history of treatment for Helicobacter infection in the past Patients who have hb a1c more than 10 Diabetic patients needing insulin treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination of blood sugar. Timepoint: The level of HbA1c and FBS before starting the treatment of Helicobacter pylori infection and after proving its eradication with the determination of Helicobacter pylori antigen in stool by PCR method, HbA1c is measured again three months after the start of treatment and the difference between HbA1c and FBS before and after treatment is compared. Method of measurement: blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTaha Rezayian
Qazvin University of Medical Sciences
Outcome results
None listed